Correlation Between Pmv Pharmaceuticals and Renovaro Biosciences

Can any of the company-specific risk be diversified away by investing in both Pmv Pharmaceuticals and Renovaro Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pmv Pharmaceuticals and Renovaro Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Pmv Pharmaceuticals and Renovaro Biosciences, you can compare the effects of market volatilities on Pmv Pharmaceuticals and Renovaro Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pmv Pharmaceuticals with a short position of Renovaro Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pmv Pharmaceuticals and Renovaro Biosciences.

Diversification Opportunities for Pmv Pharmaceuticals and Renovaro Biosciences

-0.18

Correlation Coefficient

Pmv Pharmaceuticals  Renovaro Biosciences

Good diversification

The 3 months correlation between Pmv and Renovaro is -0.18. Overlapping area represents the amount of risk that can be diversified away by holding Pmv Pharmaceuticals and Renovaro Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Renovaro Biosciences and Pmv Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pmv Pharmaceuticals are associated (or correlated) with Renovaro Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Renovaro Biosciences has no effect on the direction of Pmv Pharmaceuticals i.e., Pmv Pharmaceuticals and Renovaro Biosciences go up and down completely randomly.

Pair Corralation between Pmv Pharmaceuticals and Renovaro Biosciences

Given the investment horizon of 90 days Pmv Pharmaceuticals is expected to generate 0.62 times more return on investment than Renovaro Biosciences. However, Pmv Pharmaceuticals is 1.61 times less risky than Renovaro Biosciences. It trades about 0.22 of its potential returns per unit of risk. Renovaro Biosciences is currently generating about 0.0 per unit of risk. If you would invest  87.00  in Pmv Pharmaceuticals on May 6, 2025 and sell it today you would earn a total of  53.00  from holding Pmv Pharmaceuticals or generate 60.92% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Pmv Pharmaceuticals  vs.  Renovaro Biosciences

Pmv Pharmaceuticals

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Pmv Pharmaceuticals are ranked lower than 17 (%) of all global equities and portfolios over the last 90 days. Even with relatively unfluctuating basic indicators, Pmv Pharmaceuticals reported solid returns over the last few months and may actually be approaching a breakup point.

Renovaro Biosciences

Risk-Adjusted Performance

Very Weak

Over the last 90 days Renovaro Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Renovaro Biosciences is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Pmv Pharmaceuticals and Renovaro Biosciences

The main advantage of trading using opposite Pmv Pharmaceuticals and Renovaro Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pmv Pharmaceuticals position performs unexpectedly, Renovaro Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Renovaro Biosciences will offset losses from the drop in Renovaro Biosciences' long position.

The idea behind Pmv Pharmaceuticals and Renovaro Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.